Past Events

November 2013

  • November 18, 2013: Symposium on Assessing Adverse Epigenetic Effects of Drugs and Chemicals. Sponsored by the HESI Genomics Technical Committee. Washington, DC. (Details)

October 2013

  • October 10-11, 2013: Scientific Workshop - Translational Alternative Models and Biomarkers Predictive of Drug or Chemical Cardiovascular Risk. Co-sponsored by the HESI Cardiac Safety Technical Committee. NIEHS, Research Triangle Park, NC. (Details)
  • October 22: Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions. Sponsored by the HESI Immunotoxicology Committee. Silver Spring, MD. (Details)

September 2013

  • September 2-4, 2013: HESI presentations at the 49th Congress of the European Societies of Toxicology. (Details)

July 2013

  • July 23, 2013: 
    Rechanneling the Current Cardiac Risk Paradigm: 
    Arrhythmia Risk Assessment During Drug Development Without the Thorough QT Study
    . Co-sponsored by the HESI Cardiac Safety Technical Committee. Silver Spring, MD.  (Details)

June 2013

  • June 11-13, 2013: 4th Annual Meeting of the ILSI Health and Environmental Sciences Institute. Hotel Monaco, Alexandria, VA.  (Details)

May 2013

  • May 16-17, 2013: Workshop on Moving Forward in Human Cancer Risk Assessment in the Genomics Era 2.0. Co-sponsored by the HESI Application of Genomics to Mechanism-based Risk Assessment Technical Committee. Paris, France. (Details)
  • May 7-8, 2013: HESI PATC and IFBiC Biotechnology Update Symposium 2013. Co-sponsored by the HESI Protein Allergenicity Technical Committee (PATC) and the ILSI International Food Biotechnology Committee (IFBiC). (Details)

April 2013

  • April 15-16, 2013:  HESI Workshop on "Food Allergy and Safety Assessment." Co-sponsored by the HESI Protein Allergenicity Technical Committee, the ILSI Focal Point in China, the ILSI International Food Biotechnology Committee (IFBiC), the China National Center for Food Safety Risk Assessment, and the China Key Laboratory on Food Safety Risk Assessment of the Ministry of Health. Beijing, China. (Details)

March 2013

  • March 18-19, 2013:  HESI Workshop on "Pluripotent Stem Cells: Applications for Cardiovascular Risk Assessment." Co-sponsored by the HESI Cardiac Safety Technical Committee and the Safety Pharmacology Society. Amgen Campus, Cambridge, Massachusetts. (Details)

February 2013

  • February 7-8, 2013:  HESI Workshop on "Developing Guidance for Alternatives Assessment." Sponsored by the HESI Frameworks for Alternative Chemical Assessment and Selection of Safer, Sustainable Alternatives Subcommittee. Research Triangle Park, NC. (Details)

(Older HESI events)

 

 

 

Chinese Japanese Portugese Spanish